¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"planning target volume"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • blood volume
    Ç÷¾×·®
  • circulating blood volume
    ¼øÈ¯Ç÷¾×·®
  • expiratory reserve volume
    ³¯¼û¿¹ºñ·®, È£±â¿¹ºñ·®
  • effective circulating volume
    À¯È¿¼øÈ¯¿ëÀû
  • end-diastolic volume
    È®Àå±â¸»¿ëÀû
  • end-systolic volume
    ¼öÃà±â¸»¿ëÀû
  • flow volume curve
    À¯·®¿ë·®°î¼±
  • forced expiratory volume
    ³ë·Â³¯¼ûÆóȰ·®, °­Á¦È£±â·®
  • inspiratory reserve volume
    µé¼û¿¹ºñ·®, ¿¹ºñÈí±â·®
  • minute volume
    1. ºÐ´çÈ£Èí·® 2. ºÐ´ç¹ÚÃâ·®
  • mean corpuscular volume
    Æò±ÕÀûÇ÷±¸¿ëÀû
  • mean platelet volume
    Æò±ÕÇ÷¼ÒÆÇ¿ëÀû
  • plasma volume expander
    Ç÷ÀåÁõ·®Á¦
  • pressure volume curve
    ¾Ð·Â¿ëÀû°î¼±
  • pressure volume relation
    ¾Ð·Â¿ëÀû°ü°è
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lung volume
    Æó¿ëÀû, ÇãÆÄºÎÇÇ
  • mean corpuscular volume
    Æò±ÕÀûÇ÷±¸¿ëÀû
  • packed cell volume
    ÃæÀü¼¼Æ÷¿ëÀû, ³óÃ༼Æ÷¿ëÀû
  • residual volume
    Àܱⷮ, ³²Àº°ø±â·®
  • stroke volume
    ÀÏȸ¹ÚÃâ·®
  • tidal volume
    ÀÏȸȣÈí·®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • target sign
    Ç¥Àû¡ÈÄ
  • target
    Ç¥Àû
  • volume acquisition
    ¿ëÀûȹµæ
  • blood volume
    Ç÷¾×·®
  • circulating blood volume
    ¼øÈ¯Ç÷¾×·®
  • flow volume curve
    À¯·®¿ë·®°î¼±
  • pressure volume curve
    ¾Ð·Â¿ëÀû°î¼±
  • volume conduction
    º¼·ýÀüµµ
  • volume elasticity coefficient
    ¿ëÀûź·Â·ü
  • pressure volume diagram
    ¾Ð·Â¿ëÀû±×¸²Ç¥
  • volume dilatometer
    ºÎÇÇÆØÃ¢°è, ¿ëÀûÆØÃ¢°è
  • effective blood volume
    À¯È¿Ç÷¾×·®
  • effective circulating volume
    À¯È¿¼øÈ¯¿ëÀû
  • end-diastolic volume
    È®Àå±â¸»¿ëÀû
  • end-systolic volume
    ¼öÃà±â¸»¿ëÀû
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Vd : volume of distribution
    ºÐÆ÷¿ëÀû.
  • alveolar ventilation volume
    ÆóÆ÷ȯ±â¿ëÀû
  • alveolar volume
    ÆóÆ÷¿ëÀû
  • gross tumor volume, GTV
    À°¾ÈÀûÁ¾¾çüÀû
  • high volume sampler
    ÇÏÀ̺¼·ý»ùÇ÷¯.
  • inspiratory reserve volume
    Èí½Ä(¼º)¿¹ºñ¿ëÀû(ýåãÓàõçãÝáé»îÝ), Èí±âÀܱⷮ( ¡­íÑѨåÖ).
  • inspiratory triggering volume
    Èí±âÀ¯¹ß·®.
  • phonatory air volume
    ¹ß¼º½Ã°ø±â·®(¡­ãÁÍöѨåÖ).
  • plasma expander =p. volume e.
    ´ë¿ëÇöóÁ<Ç÷Àå>, ÇöóÁ<Ç÷Àå(úìíì )>Áõ·®Á¦(¡­ñòåÖð¥).
  • plasma volume
    Ç÷Àå·®(úìíìåÖ).
  • pressure volume curve
    ¾Ð·Â¿ëÀû°î¼±(äâæ³é»îÝÍØàÊ).
  • pressure volume diagram
    ¾Ð·®µµ, ¾Ð·Â¿ëÀû°î¼±.
  • pressure volume relation
    ¾Ð·Â¿ëÀû°ü°è.
  • red cell volume
    ÀûÇ÷±¸¿ëÀû(îåúìϹ é»îÝ).
  • red corpuscle volume
    ÀûÇ÷±¸¿ëÀû(îåúìϹé»îÝ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • median target absorbed dose
    Áß¾ÓÇ¥ÀûÈí¼ö¼±·®
  • median target dose
    Áß¾ÓÇ¥Àû¼±·®
  • minimum target dose
    ÃÖ¼ÒÇ¥Àû¼±·®
  • modal target dose
    ÃÖºóÇ¥Àû¼±·®
  • radiation,target theory of
    ¡­ÀÇ Ç¥ÀûÀÌ·Ð(¡­øöîÜìµÖå)
  • single target multi-hit model
    ´ÜÀÏÇ¥Àû´Ù¹ßÀûÁß ¸ðµ¨
  • source-target distance, STD
    ¼±¿øÇ¥Àû°£°Å¸®
  • target
    Ç¥Àû(øöîÜ)
  • target cell
    Ç¥Àû¼¼Æ÷
  • target cell anemia
    Ç¥ÀûÀûÇ÷±¸¼º ºóÇ÷(øöîÜ îåúìϹàõÞ¸úì).
  • target cell anemia
    Ç¥ÀûÀûÇ÷?úÔºóÇ÷(øöîÜ îåúìϹàõÞ¸úì)
  • target configuration
    °ú³á ¸ð¾ç (Ç¥Àû¸ð¾ç)
  • target configuration
    °ú³á ¸ð¾ç (Ù¼åÆ)
  • target glands
    Ç¥Àû¼±(øöîÜàÍ).
  • target lesion
    Ç¥Àû º´º¯
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • specific retention volume
    ºñ Àú·ù ¿ëÀû(ÝïîÍ×µé»îÝ)
  • void volume
    °ø°£ ¿ëÀû(ÍöÊàé»îÝ)
  • volume fraction
    ¿ëÀû ºÐȹ(é»îÝÝÂüñ)
  • volume receptor
    ¿ëÀû ¼ö¿ë±â(é»îÝáôé»Ðï)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • stroke volume
    (ÀÏȸ)¹ÚÃâ·®
  • tidal volume
    ÀÏÈ£Èí·®, ÀÏÈ£Èí¿ëÀû
  • volume
    ºÎÇÇ, ¿ëÀû, ¡ìÃ¥ÀÇ¡í±Ç
  • volume acquisition
    ¿ëÀûȹµæ
  • volume averaging effect
    ¿ëÀûÆò±ÕÈ­È¿°ú
  • volume coil
    ¿ëÀûÄÚÀÏ
  • volume element = voxel
    È­Àû¼Ò
  • volume gradient echo technique
    ¿ëÀû°æ»ç¿¡ÄÚ±â¹ý
  • volume magnetic susceptibility
    ¿ëÀûÀÚÈ­À²
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CO   1) Cardiac Output
  = Stroke Volume x HR
  Stroke Volume °áÁ¤ÀÎÀÚ<...
MCV mean cell volume; mean clinical value; mean corpuscular volume; median cell volume; motor conduction...
DOTC Dameshek's oval target cell
FTAG, F-TAG fast-binding target-attaching globulin
MLTI mixed lymphocyte target interaction
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
TPS Treatment Planning Systems
FRT FLP recognition target
NTE Neuropathy Target Esterase
T Target
TCI Target Controlled Infusion
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • circulating blood volume
    ¼øÈ¯ Ç÷¾×·®
  • colloidal volume expander
    ?
  • constant volume
    ÀÏÁ¤ ºÎÇÇ, Á¤Àû
  • corpuscular volume
    ÀûÇ÷±¸ üÀû, ÀûÇ÷±¸ °³°³ÀÇ Ã¼Àû
  • dose-volume histogram
    ¼±·® üÀû È÷½ºÅä±×¶÷, ¼±·® üÀûÇ¥
  • effective arterial volume
    À¯È¿ µ¿¸ÆÇ÷·®
  • effective blood volume
    À¯È¿ Ç÷¾×·®
  • equilibrium volume
    ÆòÇü ºÎÇÇ, ÆòÇü ¿ëÀû
  • expiratory reserve volume
    È£½Ä¼º ¿¹ºñ ¿ëÀû, È£±â ¿¹ºñ·®, ¿¹ºñ È£±â·®
    ¾ÈÁ¤ »óÅÂÀÇ È£½Ä ÈÄ ÃÖ´ë·Î È£ÃâÇÒ ¼ö ÀÖ´Â °ø±â·®À¸·Î¼­, ¾à 1200mlÀÌ´Ù.
  • flow volume curve
    À¯·®±â·® °î¼±
  • forced expiratory volume
    °­Á¦ È£±â·®, °­Á¦ ÆóȰ·®, ³ë·Â È£±â ÆóȰ·®
  • left ventricular end-diastolic volume
    Á ½É½Ç À̿ϱ⸻ ¿ëÀû
  • mean cell volume
    Æò±Õ ÀûÇ÷±¸ ¿ëÀû
  • mean corpuscular volume
    ÀûÇ÷±¸ÀÇ Æò±Õ ¿ëÀû, Æò±Õ ÀûÇ÷±¸ ¿ëÀû
    MCV´Â ÀûÇ÷±¸ ÇÑ °³ ÇÑ °³ÀÇ Æò±Õ ¿ëÀûÀ» ¥ì3À¸·Î Ç¥½ÃÇÑ °Í.
  • molar volume
    ¸ô ºÎÇÇ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
patient care planning Usually a written medical and nursing care program designed for a particular patient.
(12 Dec 1998)
city planning Comprehensive planning for the physical development of the city.
(12 Dec 1998)
community health planning Planning that has the goals of improving health, improving accessibility to health services, and promoting efficiency in the provision of services and resources on a comprehensive basis for a whole community.
(12 Dec 1998)
planning In cancer care, this consists of individualising the patients treatment plan by the study of published literature, consultation with specialist colleagues, calculation of dosages and schedules and designing the protocol.
(16 Dec 1997)
planning techniques Procedures, strategies, and theories of planning.
(12 Dec 1998)
pregnancy planning Pregnancy planning addresses issues of nutrition, vitamins, body weight, exercise, and potentially harmful medications and illnesses as well as immunizations and genetic counseling.
(12 Dec 1998)
health facility planning Areawide planning for health care institutions on the basis of projected consumer need.
(12 Dec 1998)
health planning Planning for needed health and/or welfare services and facilities.
(12 Dec 1998)
health planning councils Organised groups serving in advisory capacities related to health planning activities.
(12 Dec 1998)
health planning guidelines Recommendations for directing health planning functions and policies. These may be mandated by pl93-641 and issued by the department of health and human services for use by state and local planning agencies.
(12 Dec 1998)
health planning organizations Organizations involved in all aspects of health planning activities.
(12 Dec 1998)
health planning support Financial resources provided for activities related to health planning and development.
(12 Dec 1998)
health planning technical assistance The provision of expert assistance in developing health planning programs, plans as technical materials, etc., as requested by health systems agencies or other health planning organizations.
(12 Dec 1998)
hospital planning Areawide planning for hospitals or planning of a particular hospital unit on the basis of projected consumer need. This does not include hospital design and construction or architectural plans.
(12 Dec 1998)
social planning Interactional process combining investigation, discussion, and agreement by a number of people in the preparation and carrying out of a program to ameliorate conditions of need or social pathology in the community. It usually involves the action of a formal political, legal, or recognised voluntary body.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á